N-(Adamantan-1-yl)-2-{[3-cyano-6-(3,4-dimethoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl]sulfanyl}acetamide

Catalog No. :
ACZSTQ181
CAS No. :
487032-04-2
Molecular Formula :
C27H28F3N3O3S
Molecular Weight :
531.60

IUPAC Name:N-(adamantan-1-yl)-2-((3-cyano-6-(3,4-dimethoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl)thio)acetamide

N-(Adamantan-1-yl)-2-{[3-cyano-6-(3,4-dimethoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl]sulfanyl}acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$321.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(Adamantan-1-yl)-2-{[3-cyano-6-(3,4-dimethoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl]sulfanyl}acetamide
IUPAC NameN-(adamantan-1-yl)-2-((3-cyano-6-(3,4-dimethoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl)thio)acetamide
Molecular FormulaC27H28F3N3O3S
Molecular Weight531.60
SMILESO=C(NC12CC3CC(C2)CC(C3)C1)CSC4=NC(C5=CC=C(OC)C(OC)=C5)=CC(C(F)(F)F)=C4C#N
InChI KeyDEGMSISJHUNBRO-UHFFFAOYSA-N
SynonymN-(1-adamantyl)-2-{[3-cyano-6-(3,4-dimethoxyphenyl)-4-(trifluoromethyl)pyridin-2-yl]sulfanyl}acetamide;Acetamide, 2-[[3-cyano-6-(3,4-dimethoxyphenyl)-4-(trifluoromethyl)-2-pyridinyl]thio]-N-tricyclo[3.3.1.13,7]dec-1-yl-
CAS No.487032-04-2

Synthetic Route by SureRoute

1. ACZSTQ181 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWHKO418 route compound structure diagram
    ACWHKO418768-94-5 In Stock
  4. Then
  5. ACZSTQ181 route product structure diagram
    ACZSTQ181487032-04-2
Inquiry

2. ACZSTQ181 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZSTQ181 route product structure diagram
    ACZSTQ181487032-04-2
Inquiry

Comments (0)